Table 1.
Baseline characteristic of patients receiving remimazolam combined with or without remifentanil for anaesthesia induction.
| Parameters | Normal saline group (n = 84) | Remifentanil-1 group (n = 85) | Remifentanil-2 group (n = 82) | p value |
|---|---|---|---|---|
| Age; years | 37.6 (8.5) | 39.2 (9.7) | 36.4 (8.3) | 0.128 |
| Height; cm | 157.9 (5.8) | 157.7 (5.6) | 157.7 (5.1) | 0.974 |
| Body weight; kg | 55.5 (8.8) | 56.5 (10.9) | 53.7 (8.8) | 0.160 |
| BMI; kg m–2 | 22.2 (3.2) | 22.7 (4.1) | 21.5 (2.9) | 0.079 |
| Mallampati score | 0.235 | |||
| I | 80(95%) | 75(88%) | 76(93%) | |
| II | 4(5%) | 10(12%) | 6(7%) | |
| ASA physical status | 0.414 | |||
| I | 79(94%) | 75(88%) | 74(90%) | |
| II | 5(6%) | 10(12%) | 8(10%) |
BMI, body mass index; ASA, American Society of Anesthesiologists.
Values are mean (SD) or frequency (%).